clopidogrel tad
tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
zoledronic acid pharmagen 4 mg/5 ml
pharmagen cz s.r.o., Česká republika - kyselina zoledrónová - 87 - varia i
cerebrolysin 1 ml
ever neuro pharma gmbh, rakúsko - iné liečivá na centrálnu nervovú sústavu - 04 - aminoacida
thiogamma 600 oral
wörwag pharma gmbh & co. kg, nemecko - kyselina tioktová - 87 - varia i
metfogamma 500
wörwag pharma gmbh & co. kg, nemecko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)
metfogamma 1000
wörwag pharma gmbh & co. kg, nemecko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)
dabahib 150 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 75 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
asigefort 50 mg/1 000 mg filmom obalené tablety
tad pharma gmbh, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
asigefort 50 mg/850 mg filmom obalené tablety
tad pharma gmbh, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)